Melanoma, cutaneous malignant, susceptibility to, 2

Synonyms: CDKN2A-Related Cutaneous Malignant Melanoma; Cutaneous malignant melanoma 2

Summary

Malignant melanoma is a neoplasm of pigment-producing cells called melanocytes that occurs most often in the skin, but may also occur in the eyes, ears, gastrointestinal tract, leptomeninges, and oral and genital mucous membranes (summary by Habif, 2010). For a discussion of genetic heterogeneity of cutaneous malignant melanoma, see CMM1 (155600). [from OMIM]

Available tests

89 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Clinical tests (89 available)

Cytogenetics Tests

FISH-interphase (1)

Molecular Genetics Tests

Genes See tests for all associated and related genes

Associated genes Help
Genes reported to contribute to the condition.

CDKN2A
296 tests
Also known as: ARF, CAI2, CDK4I, CDKN2, CMM2, INK4, INK4A, MLM, MTS-1, MTS1, P14, P14ARF, P16, P16-INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16, CDKN2A
Summary: cyclin dependent kinase inhibitor 2A

Imported from Human Phenotype Ontology (HPO)

Show all Hide all

Neoplasm
- Malignant melanoma of skin
  Malignant melanoma of skin
  - MedGen UID: 57486
  - Concept ID: C0151779
  - Finding: Neoplastic Process
  Neoplasm
  See: Feature record | Search on this feature

Reviews

Clinical resources

Molecular resources

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.